Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference43 articles.
1. Allahyari, H., Heidari, S., Ghamgosha, M., Saffarian, P., Amani, J., 2017. Immunotoxin: A new tool for cancer therapy. Tumour Biol. 39, 1010428317692226.
2. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program;Cardoso;Ann Oncol.,2018
3. A light-switchable bidirectional expression module allowing simultaneous regulation of multiple genes;Chen;Biochem. Biophys. Res. Commun.,2015
4. Visualizing RNA dynamics in live cells with bright and stable fluorescent RNAs;Chen;Nat. Biotechnol.,2019
5. ATG9A is overexpressed in triple negative breast cancer and its in vitro extinction leads to the inhibition of pro-cancer phenotypes;Claude-Taupin;Cells.,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engineering a porphyrin COFs encapsulated by hyaluronic acid tumor-targeted nanoplatform for sequential chemo-photodynamic multimodal tumor therapy;International Journal of Biological Macromolecules;2024-11
2. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition;ACS Applied Materials & Interfaces;2023-11-09
3. A dual drug-loaded peptide system with morphological transformation prolongs drug retention and inhibits breast cancer growth;Biomaterials Advances;2023-11
4. Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review;Frontiers in Bioengineering and Biotechnology;2023-09-12
5. Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy;Asian Journal of Pharmaceutical Sciences;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3